Know Cancer

or
forgot password

NM404 as an Imaging Agent in Patients With Non-small Cell Lung Cancer (NSCLC)


N/A
18 Years
N/A
Not Enrolling
Both
Non Small Cell Lung Cancer

Thank you

Trial Information

NM404 as an Imaging Agent in Patients With Non-small Cell Lung Cancer (NSCLC)


Inclusion Criteria:

Part 3

- Histologically or cytologically documented NSCLC with measurable of disease

- Disease is evaluable by CT scan

- At least 18 years old. Women cannot be pregnant or breastfeeding

- Karnofsky score >/= to 60

- Adequate renal/hepatic function

- Adequate blood cell count levels

Exclusion Criteria:

- Concomitant infection

- Other active cancers

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Imaging characteristics

Outcome Time Frame:

5 days

Safety Issue:

No

Principal Investigator

Anne M Traynor, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Wisconsin, Madison

Authority:

United States: Food and Drug Administration

Study ID:

H-2002-582

NCT ID:

NCT00582283

Start Date:

January 2004

Completion Date:

June 2014

Related Keywords:

  • Non Small Cell Lung Cancer
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location

University of Wisconsin Carbone Comprehensive Cancer CenterMadison, Wisconsin  53792